Determination of heptylphysostigmine in plasma by high-performance liquid chromatography with electrochemical detection
- 17 January 1992
- journal article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 573 (2) , 275-281
- https://doi.org/10.1016/0378-4347(92)80129-e
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Kinetics of cholinesterase inhibition by eptastigmine in manEuropean Journal of Clinical Pharmacology, 1991
- Inhibition of acetylcholinestense and butyrylcholinesterase after oral administration of heptastigmine in healthy volunteersEuropean Journal of Pharmacology, 1990
- Effects of metrifonate, a long-acting cholinesterease inhibitor, in alzheimer disease: Report of an open trialDrug Development Research, 1990
- New analogs of physostigmine: Alternative drugs for Alzheimer's disease?Life Sciences, 1988
- Determination of physostigmine in plasma by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1987
- A long-lasting cholinesterase inhibitor affecting neural and behavioral processesPharmacology Biochemistry and Behavior, 1987
- Anticholinesterase activity of a new carbamate, heptylphysostigmine, in view of its use in patients with Alzheimer-type dementiaEuropean Journal of Biochemistry, 1986
- A rapid, simple radiometric assay for cholinesterase, suitable for multiple determinationsAnalytical Biochemistry, 1975